Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
An Enquiry
Product Reset all filters
01 1Fabhalta
Iptacopan
Novartis
Main Therapeutic Indication : Rare Diseases and Disorders
Currency : USD
2024 Revenue in Millions : 129
2023 Revenue in Millions : 1
Growth (%) : 12,800
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF